High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti-HER2 therapy-Reference-Cited by-同舟云学术

High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti-HER2 therapy

Published:2015-09-15 Issue:1 Volume:10 Page:138-147
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Nuciforo Paolo,Thyparambil Sheeno,Aura Claudia,Garrido-Castro Ana,Vilaro Marta,Peg Vicente,Jimenez José,Vicario Rocio,Cecchi Fabiola,Hoos William,Burrows Jon,Hembrough Todd,Ferreres Juan Carles,Perez-Garcia José,Arribas Joaquin,Cortes Javier,Scaltriti Maurizio

Funder

Tumor Biomarkers Collaboration

Banco Bilbao Vizcaya Argentaria (BBVA) Foundation

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference29 articles.

1. Automated subcellular localization and quantification of protein expression in tissue microarrays;Camp;Nat. Med,2002

2. Absolute quantitation of met using mass spectrometry for clinical application: assay precision, stability, and correlation with MET gene amplification in FFPE tumor tissue;Catenacci;PloS One,2014

3. Quantitative measurements of HER2 and phospho-HER2 expression: correlation with pathologic response to neoadjuvant chemotherapy and trastuzumab;Cheng;BMC Cancer,2014

4. HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer;Denkert;Breast Cancer Res.: BCR,2013

5. Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial;Dowsett;J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol,2009

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance;Nature Reviews Clinical Oncology;2024-09-13

2. Predicting treatment outcome using kinome activity profiling in HER2+ breast cancer biopsies;iScience;2024-06

3. Unleashing the power of anti-HER2 therapies in metastatic colorectal cancer: paving the way for a brighter future;ESMO Gastrointestinal Oncology;2024-03

4. A machine learning approach to prediction of HER2/PR/ER status in metastatic breast cancer to the brain from magnetic resonance imaging.;2024-01-23

5. Clinical implications of resistance to anti-HER2 antibodies in breast cancer;Overcoming Cancers Resistant to HER-2 Antibodies;2024